Genetic features of polioviruses isolated in Tunisia, 1991-2006

Journal of Clinical Virology

Volumn 41, Issue 2, 2008, Pages 81-86

  Haddad Boubaker, S ^a   Ben Yahia, A ^a   Bahri, O ^a   Morel, V ^b   Balanant, J ^b   Delpeyroux, F ^b   Triki, H ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b INSTITUT PASTEUR   (France)

Author keywords

Poliomyelitis; Vaccine derived poliovirus; Wild poliovirus

Indexed keywords

ARTICLE; CONTROLLED STUDY; GENETIC DRIFT; GENETIC RECOMBINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLIOMYELITIS VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS RECOMBINANT;

ANIMALS; CAPSID PROTEINS; CELL LINE; GENETIC DRIFT; GENOME, VIRAL; HUMANS; MICE; MOLECULAR SEQUENCE DATA; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; TUNISIA;

EID: 38849096522     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.10.002     Document Type: Article

References (24)

1. Alexander J., Gary H., and Pallansch M. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. J Infect Dis 1 175 (1997) S176-S182
2. Arita M., Zhu S.L., Yoshida H., Yoneyama T., Miyamura T., and Shimizu H. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol 79 20 (2005) 12650-12657
3. Bahri O., Rezig D., Ben Nejma-Oueslati B., Ben Yahia A., Ben Sassi J., Hogga N., et al. Enteroviruses in Tunisia: virological surveillance over 12 years (1992-2003). J Med Microbiol 54 (2005) 63-69
4. Bruce Aylward R., and Cochi Stephen L. Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission. Bull World Health Organ 82 1 (2004) 40-46
5. Centres for Disease Control and Prevention (CDC). Outbreak of poliomyelitis-Dominican republic and Haiti. Morb. Mortal. Wkly. Rep. 49 (2000) 1094-10103
6. Centres for Disease Control and Prevention (CDC). Circulation of a type2 vaccine-derived poliovirus-Egypt, 1982-1993. Morb. Mortal. Wkly. Rep. 50 (2001) 41-42 51
7. Centres for Disease Control and Prevention (CDC). Acute flaccid paralysis associated with circulating vaccine-derived poliovirus-Philippines, 2001. Morb. Mortal. Wkly. Rep. 50 (2001) 874-875
8. Centres for Disease Control and Prevention (CDC). Acute flaccid paralysis associated with circulating vaccine-derived poliovirus-Philippines, 2001. JAMA 287 3 (2002) 311
9. Centres for Disease Control and Prevention (CDC). Public health dispatch: poliomyelitis, Madagascar, 2002. Morb. Mortal. Wkly. Rep. 51 (2002) 622
10. Combiescu M., Guillot S., Persu A., Baicus A., Pitigoi D., Balanant J., et al. Circulation of a type 1 recombinant vaccine-derived poliovirus strain in a limited area in Romania. Arch Virol 152 (2007) 727-738
11. Dedepsidis E., Karakasiliotis I., Paximadi E., Kyriakopoulou Z., Komiotis D., and Markoulatous P. Detection of unusual mutation within the VP1 region of different re-isolates of poliovirus Sabin vaccine. Virus Genes 33 2 (2006) 183-191
12. Gavrilin G., Cherkasova E., Lipskaya G., Kew O., and Agol V. Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model. J Virol 74 16 (2000) 7381-7390
13. Guillot S., Caro V., Cuervo N., Korotkova E., Combiescu M., Persu A., et al. Natural genetic exchanges between vaccines and wild poliovirus strains in humans. J Virol 74 (2000) 8434-8443
14. Kew O., Sutter R., Nottay B., McDonough M., Prevots D., Quick L., et al. Prolonged replication of type 1 vaccine derived poliovirus in immunodeficient patient. J Clin Microbiol 36 10 (1998) 2893-2899
15. Kew O., and Morris G. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296 (2002) 356-359
16. Kew O.M., Sutter R.W., de Gourville E.M., Dowdle W.R., and Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 (2005) 587-635
17. Lipskaya G., Muzychenko A., Kutitova O., Maslova S., Equestre M., Drozdov G., et al. Frequent isolation of intertypic poliovirus recombinants with poliovirus serotype 2 specificity from vaccine-associated polio cases. J Med Virol 35 (1991) 290-296
18. Rakoto-Andrianarivelo M., Rousset D., Razafindratsimandresy R., Chevaliez S., Guillot S., Balanant J., et al. High frequency of human enterovirus species C circulation in Madagascar. J Clin Microbiol 43 1 (2005) 242-249
19. Romanenkova N.I., Guillot S., Rozaeva N.R., Crainic R., Bichurina M.A., and Delpeyroux F. Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples. J Clin Microbiol 44 (2006) 4077-4084
20. Rousset D., and Rakoto-Andrianarivels M. Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 9 (2003) 885-887
21. Triki H., Bahri O., Guillot S., Van Der Avoort H.G.A.M., Ben Sassi J., Arrouj A., et al. Molecular epidemiology of poliovirus infection in Tunisia. J Med Microbiol 48 (1999) 569-576
22. Triki H., Barbouche R., Bahri O., Bejaoui M., and Dellaji K. Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia. J Clin Microbiol 41 (2003) 1203-1211
23. World Health Organization (WHO). Manual for virological investigation of poliomyelitis (2004), World Health Organization, Geneva
24. World Health Organization (WHO). Global Polio Laboratory Network Strategic Plan, 2004-2008 (2004), World Health Organization, Geneva